Literature DB >> 21105875

Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices.

Yan Zhou1, Hongmei Tang, Jianuo Liu, Jun Dong, Huangui Xiong.   

Abstract

In addition to its well-characterized effects in immune system, chemokine CC motif ligand 2 (CCL2, formerly known as monocyte chemoattractant protein-1) is believed to play an important role in brain physiological and pathological processes. It has been shown that CCL2 and its cognate receptor chemokine CC motif receptor 2 are constitutively expressed in several brain regions including the hippocampus, and the expression is up-regulated under pathological conditions. Whereas most investigations have so far focused on its involvement in CNS pathology, few studies have examined the effects of CCL2 on neuronal and synaptic physiology. In this study, we tested the effects of CCL2 on neuronal excitability and excitatory synaptic transmission in the CA1 region of rat hippocampal slices using whole-cell patch clamp techniques. Bath application of CCL2 depolarized membrane potential and increased spike firing in CA1 neuronal cells. Bath application of CCL2 also produced an increase of excitatory post-synaptic currents recorded in Schaffer-collateral fibers to CA1 synapses. Quantal analysis revealed that CCL2 increased the frequency of spontaneous excitatory post-synaptic current occurrence and mean quantal content. Taken together, our data indicate that CCL2 enhances neuronal excitability and synaptic transmission via pre-synaptic mechanisms. These results support the emerging concept that chemokines function as neuromodulators in the CNS.
© 2010 The Authors. Journal of Neurochemistry © 2010 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21105875      PMCID: PMC3018532          DOI: 10.1111/j.1471-4159.2010.07121.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

1.  Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease.

Authors:  K Ishizuka; T Kimura; R Igata-yi; S Katsuragi; J Takamatsu; T Miyakawa
Journal:  Psychiatry Clin Neurosci       Date:  1997-06       Impact factor: 5.188

2.  The end-plate potential in mammalian muscle.

Authors:  I A BOYD; A R MARTIN
Journal:  J Physiol       Date:  1956-04-27       Impact factor: 5.182

3.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

Review 4.  The regulation of quantal size.

Authors:  W Van der Kloot
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

5.  Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices.

Authors:  H Xiong; A Baskys; J M Wojtowicz
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

6.  Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem.

Authors:  S Z Meng; A Oka; S Takashima
Journal:  Brain Dev       Date:  1999-01       Impact factor: 1.961

7.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.

Authors:  K Conant; A Garzino-Demo; A Nath; J C McArthur; W Halliday; C Power; R C Gallo; E O Major
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

8.  Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain.

Authors:  A R Glabinski; V Balasingam; M Tani; S L Kunkel; R M Strieter; V W Yong; R M Ransohoff
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

9.  Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions.

Authors:  J E Simpson; J Newcombe; M L Cuzner; M N Woodroofe
Journal:  J Neuroimmunol       Date:  1998-04-15       Impact factor: 3.478

10.  Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat.

Authors:  J S Kim; S C Gautam; M Chopp; C Zaloga; M L Jones; P A Ward; K M Welch
Journal:  J Neuroimmunol       Date:  1995-02       Impact factor: 3.478

View more
  50 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

2.  Altered hippocampal synaptic transmission in transgenic mice with astrocyte-targeted enhanced CCL2 expression.

Authors:  Thomas E Nelson; Christine Hao; Jessica Manos; R M Ransohoff; Donna L Gruol
Journal:  Brain Behav Immun       Date:  2011-02-26       Impact factor: 7.217

Review 3.  Role of MCP-1 and CCR2 in alcohol neurotoxicity.

Authors:  Kai Zhang; Jia Luo
Journal:  Pharmacol Res       Date:  2018-11-22       Impact factor: 7.658

4.  Synaptic plasticity in the hippocampus shows resistance to acute ethanol exposure in transgenic mice with astrocyte-targeted enhanced CCL2 expression.

Authors:  Jennifer G Bray; Kenneth C Reyes; Amanda J Roberts; Richard M Ransohoff; Donna L Gruol
Journal:  Neuropharmacology       Date:  2012-11-16       Impact factor: 5.250

5.  CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS.

Authors:  Maria Rosito; Cristina Deflorio; Cristina Limatola; Flavia Trettel
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

6.  Cytokine changes in newborns with therapeutic hypothermia after hypoxic ischemic encephalopathy.

Authors:  C J Moon; Y A Youn; S K Yum; I K Sung
Journal:  J Perinatol       Date:  2016-09-01       Impact factor: 2.521

7.  Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.

Authors:  Chunyan Zhu; Bing Xu; Xiaohong Sun; Qiwen Zhu; Yi Sui
Journal:  Mol Neurobiol       Date:  2016-11-23       Impact factor: 5.590

8.  Transgenic mice with increased astrocyte expression of CCL2 show altered behavioral effects of alcohol.

Authors:  Jennifer G Bray; Amanda J Roberts; Donna L Gruol
Journal:  Neuroscience       Date:  2017-04-19       Impact factor: 3.590

9.  Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus.

Authors:  K Poon; D Abramova; H T Ho; S Leibowitz
Journal:  Neuroscience       Date:  2016-03-12       Impact factor: 3.590

Review 10.  Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.

Authors:  George R Breese; Darin J Knapp
Journal:  Alcohol       Date:  2016-02-24       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.